Palvella Therapeutics, Inc. reported a loss of -$11.35 million in the third quarter, with earnings of -$1.03 per share compared to last year’s -$3.94 per share. The company’s GAAP earnings also showed a decrease from -$6.97 million to -$11.35 million.

Read more at Nasdaq: Palvella Therapeutics, Inc. Loss At -$11.35 Mln In Q3